Treatments for Urogynaecological Problems and Patient Selfreports

Launched by SWANSEA UNIVERSITY · Sep 14, 2015

Keywords

ClinConnect Summary

This clinical trial is studying how different treatments for urogynaecological problems, such as pelvic floor dysfunction and cancers, affect patients' health, quality of life, and emotional well-being. The researchers want to understand how these treatments impact not only physical health but also how patients feel about their health and their lives overall. To do this, they will collect information from patients both before and after their treatments, using simple questionnaires that will take about 30 minutes to complete.

To participate in this trial, women aged 65 to 74 who are referred for pelvic floor issues to Singleton Hospital in Swansea, UK, may be eligible. The researchers will ask for consent before starting and will gather information during routine appointments over a period of five years. This means patients will fill out questionnaires at the start of their treatment and then again during follow-up appointments. The goal is to see how well treatments work and how they influence patients' overall well-being, helping to improve future care for women with similar conditions.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • consenting patients who are referred for pelvic floor problems to Singleton Hospital Swansea, UK.
• Exclusion Criteria:
• • under 18 years